Year: 2012
Type: review
Abstract: Nitric oxide (NO), a key regulator of cardiovascular function, is synthesized from L-arginine and oxygen by the enzyme nitric oxide synthase (NOS). This reaction requires tetrahydrobiopterin (BH4) as a cofactor. BH4 is synthesized from guanosine triphosphate (GTP) by GTP cyclohydrolase I (GTPCH) and recycled from 7,8-dihydrobiopterin (BH2) by dihydrofolate reductase. Under conditions of low BH4 bioavailability relative to NOS or BH2, oxygen activation is "uncoupled" from L-arginine oxidation, and NOS produces superoxide (O (2) (-) ) instead of NO. NOS-derived superoxide reacts with NO to produce peroxynitrite (ONOO(-)), a highly reactive anion that rapidly oxidizes BH4 and propagates NOS uncoupling. BH4 depletion and NOS uncoupling contribute to overload-induced heart failure, hypertension, ischemia/reperfusion injury, and atrial fibrillation. L-arginine depletion, methylarginine accumulation, and S-glutathionylation of NOS also promote uncoupling. Recoupling NOS is a promising approach to treating myocardial and vascular dysfunction associated with heart failure.
Source: Current Heart Failure Reports
Authors: Matthew S. Alkaitis, Mark J. Crabtree
Institutions: John Radcliffe Hospital, University of Oxford
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: nitric oxide synthase, tetrahydrobiopterin, superoxide, peroxynitrite, GTP cyclohydrolase I, dihydrofolate reductase, 7,8-dihydrobiopterin, L-arginine, methylarginines, S-glutathionylation, heart failure, hypertension, ischemia-reperfusion injury, atrial fibrillation, cardiovascular dysfunction
Open Access status: hybrid
Estimated APC paid: $4,490
OpenAlex ID: W2114719488
